REG - Hikma Pharmaceutical - Transaction in Own Shares
11/03/2022 18:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220311:nRSK5716Ea&default-theme=true
RNS Number : 5716E Hikma Pharmaceuticals Plc 11 March 2022
Hikma Pharmaceuticals PLC
Share Buyback Programme
London, 11 March 2022
Hikma Pharmaceuticals PLC ("Hikma") announces today that it has purchased the
following number of its ordinary shares on the London Stock Exchange and/or on
BATS and/or on Chi-X trading venues from Citigroup Global Markets Limited
("Citi"). The repurchased shares will be cancelled.
London Stock Exchange BATS Trading Venue Chi-X Trading Venue
Number of ordinary shares purchased: 10,599 6,418 -
Highest price paid (per ordinary share): £19.8300 £19.8300 -
Lowest price paid (per ordinary share): £19.7950 £19.7950 -
Volume weighted average price paid (per ordinary share): £19.8183 £19.8169 -
Such purchases form part of Hikma's share buyback programme announced on 24
February 2022.
Following the settlement of the above purchases and cancellation of the
purchased ordinary shares, the total number of ordinary shares in issue shall
be 243,701,581 ordinary shares and the total number of ordinary shares held in
treasury is 12,833,233 ordinary shares. Therefore, following the above
purchases total voting rights are 230,868,348 ordinary shares.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), the detailed breakdown of individual trades made by Citi on
behalf of Hikma as part of the buyback programme is set out below.
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
Schedule of Purchases - Individual Transactions
Date of Transaction Time of Transaction Number of Shares Price Per Share (GBp) Trading Venue Transaction Reference Number
11/03/2022 16:13:17 140 1,980.00 BATE xsqArH2G6TD
11/03/2022 16:12:37 175 1,979.50 XLON xsqArH2G7nC
11/03/2022 16:12:31 43 1,980.00 XLON xsqArH2G7@e
11/03/2022 16:12:31 103 1,980.00 XLON xsqArH2G7@g
11/03/2022 16:12:31 138 1,980.00 BATE xsqArH2G7@i
11/03/2022 16:12:02 135 1,980.00 XLON xsqArH2G7BH
11/03/2022 16:11:52 46 1,980.50 XLON xsqArH2G7I7
11/03/2022 16:11:52 38 1,980.50 XLON xsqArH2G7I9
11/03/2022 16:11:52 97 1,980.50 BATE xsqArH2G7IB
11/03/2022 16:11:43 123 1,981.00 BATE xsqArH2G7Rh
11/03/2022 16:11:43 112 1,981.00 XLON xsqArH2G7Rf
11/03/2022 16:11:37 131 1,981.50 BATE xsqArH2G4dW
11/03/2022 16:11:37 84 1,981.50 XLON xsqArH2G4aS
11/03/2022 16:11:37 35 1,981.50 XLON xsqArH2G4aU
11/03/2022 16:11:28 19 1,982.00 XLON xsqArH2G4jH
11/03/2022 16:11:28 117 1,982.00 BATE xsqArH2G4jL
11/03/2022 16:11:28 127 1,982.00 XLON xsqArH2G4jJ
11/03/2022 16:10:35 28 1,982.00 BATE xsqArH2G4BU
11/03/2022 16:10:35 18 1,982.00 BATE xsqArH2G4AW
11/03/2022 16:10:35 75 1,982.00 BATE xsqArH2G4AY
11/03/2022 16:10:22 54 1,983.00 XLON xsqArH2G4IL
11/03/2022 16:07:35 117 1,982.50 BATE xsqArH2G2K8
11/03/2022 16:07:32 72 1,983.00 XLON xsqArH2G2NT
11/03/2022 16:07:32 139 1,983.00 BATE xsqArH2G2MX
11/03/2022 16:07:30 6 1,983.00 BATE xsqArH2G2GW
11/03/2022 16:07:30 389 1,983.00 BATE xsqArH2G2GY
11/03/2022 16:07:30 175 1,983.00 XLON xsqArH2G2Ga
11/03/2022 16:07:21 548 1,983.00 XLON xsqArH2G2Rh
11/03/2022 14:10:20 127 1,982.00 BATE xsqArH2I@B@
11/03/2022 14:08:41 51 1,982.00 BATE xsqArH2I$Me
11/03/2022 14:08:41 13 1,982.00 BATE xsqArH2I$Mi
11/03/2022 14:08:41 94 1,982.00 XLON xsqArH2I$Mg
11/03/2022 14:08:41 202 1,982.50 XLON xsqArH2I$Mk
11/03/2022 14:08:41 68 1,982.50 BATE xsqArH2I$Mm
11/03/2022 14:08:41 30 1,982.50 BATE xsqArH2I$Mo
11/03/2022 14:08:41 206 1,983.00 BATE xsqArH2I$Mw
11/03/2022 14:08:41 15 1,983.00 BATE xsqArH2I$M@
11/03/2022 14:08:41 493 1,983.00 XLON xsqArH2I$Mu
11/03/2022 13:55:34 75 1,983.00 XLON xsqArH2IcQm
11/03/2022 13:54:48 135 1,983.00 XLON xsqArH2Idum
11/03/2022 13:52:46 54 1,983.00 BATE xsqArH2Iam6
11/03/2022 13:49:29 2 1,983.00 BATE xsqArH2IYXe
11/03/2022 13:49:29 21 1,983.00 BATE xsqArH2IYXg
11/03/2022 13:49:29 63 1,983.00 BATE xsqArH2IYXi
11/03/2022 13:01:40 102 1,983.00 XLON xsqArH2IRT6
11/03/2022 13:01:40 6 1,983.00 BATE xsqArH2IRT8
11/03/2022 13:01:40 116 1,983.00 BATE xsqArH2IRTA
11/03/2022 11:37:39 96 1,983.00 XLON xsqArH2JZ29
11/03/2022 11:23:16 108 1,980.50 XLON xsqArH2JMyx
11/03/2022 11:23:16 53 1,981.00 XLON xsqArH2JMy8
11/03/2022 11:23:16 73 1,981.00 XLON xsqArH2JMyA
11/03/2022 11:23:11 190 1,981.50 XLON xsqArH2JM@S
11/03/2022 11:23:11 36 1,982.00 XLON xsqArH2JMvW
11/03/2022 11:23:11 400 1,982.00 XLON xsqArH2JMvY
11/03/2022 11:20:15 120 1,982.50 BATE xsqArH2JN43
11/03/2022 11:20:15 117 1,982.50 XLON xsqArH2JN4z
11/03/2022 11:20:15 139 1,982.50 XLON xsqArH2JN4$
11/03/2022 11:19:09 167 1,982.50 XLON xsqArH2JNTW
11/03/2022 11:18:54 279 1,983.00 XLON xsqArH2JNO4
11/03/2022 11:18:54 173 1,983.00 BATE xsqArH2JNO6
11/03/2022 11:14:32 102 1,983.00 BATE xsqArH2JL6U
11/03/2022 11:12:19 10 1,982.50 XLON xsqArH2JIzZ
11/03/2022 11:12:19 54 1,982.50 XLON xsqArH2JIzf
11/03/2022 11:12:19 12 1,982.50 XLON xsqArH2JIzh
11/03/2022 11:12:19 40 1,982.50 XLON xsqArH2JIzo
11/03/2022 11:12:19 154 1,982.50 XLON xsqArH2JIzq
11/03/2022 11:12:19 138 1,982.00 XLON xsqArH2JIz3
11/03/2022 11:12:09 59 1,980.00 XLON xsqArH2JIuX
11/03/2022 11:11:41 154 1,980.00 BATE xsqArH2JIM9
11/03/2022 11:11:01 3 1,980.50 BATE xsqArH2JJfs
11/03/2022 11:10:58 306 1,981.50 BATE xsqArH2JJhY
11/03/2022 11:10:58 16 1,981.50 BATE xsqArH2JJha
11/03/2022 11:10:56 95 1,981.50 BATE xsqArH2JJgH
11/03/2022 11:10:56 68 1,981.50 BATE xsqArH2JJgJ
11/03/2022 11:10:56 100 1,980.50 BATE xsqArH2JJgT
11/03/2022 11:10:56 40 1,981.50 BATE xsqArH2JJr@
11/03/2022 11:10:56 119 1,980.50 XLON xsqArH2JJr9
11/03/2022 11:10:56 80 1,981.00 XLON xsqArH2JJrJ
11/03/2022 11:10:56 194 1,981.00 XLON xsqArH2JJrL
11/03/2022 11:10:56 6 1,981.00 BATE xsqArH2JJrN
11/03/2022 11:10:56 96 1,981.00 BATE xsqArH2JJrP
11/03/2022 11:09:43 19 1,981.50 BATE xsqArH2JJN0
11/03/2022 11:09:24 21 1,980.00 BATE xsqArH2JJQr
11/03/2022 11:09:24 157 1,980.00 XLON xsqArH2JJQs
11/03/2022 11:09:24 119 1,979.50 XLON xsqArH2JJQ9
11/03/2022 11:09:24 24 1,979.50 BATE xsqArH2JJQB
11/03/2022 11:09:24 38 1,979.50 BATE xsqArH2JJQD
11/03/2022 11:09:24 108 1,980.00 BATE xsqArH2JJQH
11/03/2022 11:09:24 85 1,980.00 XLON xsqArH2JJQF
11/03/2022 11:09:24 189 1,980.00 XLON xsqArH2JJQJ
11/03/2022 11:08:04 131 1,980.50 XLON xsqArH2JG2K
11/03/2022 11:05:45 55 1,980.50 XLON xsqArH2JH7Y
11/03/2022 11:05:45 158 1,980.50 XLON xsqArH2JH7y
11/03/2022 11:05:36 38 1,980.50 XLON xsqArH2JH0f
11/03/2022 11:05:36 51 1,980.00 XLON xsqArH2JH0t
11/03/2022 11:04:38 5 1,980.00 BATE xsqArH2JHSH
11/03/2022 11:04:38 200 1,980.00 BATE xsqArH2JHSJ
11/03/2022 11:04:38 25 1,980.00 BATE xsqArH2JHSL
11/03/2022 11:04:38 33 1,980.00 BATE xsqArH2JHSP
11/03/2022 11:03:42 68 1,979.50 XLON xsqArH2JUey
11/03/2022 11:03:42 119 1,980.00 XLON xsqArH2JUe0
11/03/2022 11:03:39 53 1,980.50 XLON xsqArH2JUhB
11/03/2022 11:03:39 200 1,980.50 XLON xsqArH2JUhD
11/03/2022 11:03:39 21 1,980.50 XLON xsqArH2JUhF
11/03/2022 11:03:39 88 1,981.00 BATE xsqArH2JUhJ
11/03/2022 11:03:39 149 1,981.50 BATE xsqArH2JUhH
11/03/2022 11:03:38 224 1,983.00 XLON xsqArH2JUgo
11/03/2022 11:03:38 63 1,983.00 XLON xsqArH2JUgq
11/03/2022 11:03:38 32 1,983.00 XLON xsqArH2JUgs
11/03/2022 11:03:38 192 1,983.00 XLON xsqArH2JUg$
11/03/2022 11:03:37 195 1,983.00 XLON xsqArH2JUg5
11/03/2022 11:03:37 1 1,983.00 XLON xsqArH2JUgB
11/03/2022 11:03:37 130 1,983.00 XLON xsqArH2JUgD
11/03/2022 11:03:37 32 1,983.00 XLON xsqArH2JUgF
11/03/2022 11:03:37 145 1,983.00 XLON xsqArH2JUrh
11/03/2022 11:03:37 32 1,983.00 XLON xsqArH2JUrj
11/03/2022 11:03:37 62 1,983.00 XLON xsqArH2JUrs
11/03/2022 11:03:37 13 1,983.00 XLON xsqArH2JUr3
11/03/2022 11:03:37 102 1,983.00 XLON xsqArH2JUr5
11/03/2022 11:03:37 84 1,980.50 BATE xsqArH2JUrU
11/03/2022 11:03:37 112 1,980.50 BATE xsqArH2JUqa
11/03/2022 11:03:37 274 1,980.50 XLON xsqArH2JUqi
11/03/2022 11:02:35 50 1,981.50 BATE xsqArH2JUMv
11/03/2022 11:02:35 61 1,981.50 BATE xsqArH2JUMJ
11/03/2022 11:02:35 50 1,981.50 BATE xsqArH2JUH3
11/03/2022 11:02:35 259 1,981.50 BATE xsqArH2JUHL
11/03/2022 11:02:22 4 1,981.50 BATE xsqArH2JUON
11/03/2022 11:02:22 7 1,981.50 BATE xsqArH2JUOP
11/03/2022 11:02:01 45 1,981.50 BATE xsqArH2JVWt
11/03/2022 11:02:01 273 1,981.00 XLON xsqArH2JVW2
11/03/2022 11:02:01 99 1,981.00 BATE xsqArH2JVW8
11/03/2022 10:59:54 102 1,981.50 BATE xsqArH2JSdf
11/03/2022 10:58:51 103 1,981.00 BATE xsqArH2JS7J
11/03/2022 10:58:51 60 1,981.00 BATE xsqArH2JS7L
11/03/2022 10:58:51 118 1,980.00 XLON xsqArH2JS6g
11/03/2022 10:58:51 50 1,980.00 BATE xsqArH2JS6e
11/03/2022 10:58:51 18 1,980.00 BATE xsqArH2JS6i
11/03/2022 10:58:51 152 1,980.50 XLON xsqArH2JS6m
11/03/2022 10:58:51 46 1,980.50 XLON xsqArH2JS6o
11/03/2022 10:58:51 75 1,980.50 XLON xsqArH2JS6q
11/03/2022 10:58:51 4 1,980.50 BATE xsqArH2JS6y
11/03/2022 10:58:51 98 1,980.50 BATE xsqArH2JS6@
11/03/2022 10:55:08 67 1,981.50 XLON xsqArH2JQ@M
11/03/2022 10:55:08 102 1,982.00 XLON xsqArH2JQ@R
11/03/2022 10:54:46 42 1,982.00 XLON xsqArH2JQCu
11/03/2022 10:54:46 183 1,982.50 XLON xsqArH2JQFw
11/03/2022 10:54:46 125 1,983.00 BATE xsqArH2JQF@
11/03/2022 10:54:46 422 1,983.00 XLON xsqArH2JQFy
11/03/2022 10:27:24 64 1,983.00 BATE xsqArH2JEPx
11/03/2022 10:27:24 51 1,983.00 BATE xsqArH2JEPz
11/03/2022 10:27:12 100 1,983.00 BATE xsqArH2JFdI
11/03/2022 10:27:12 99 1,983.00 BATE xsqArH2JFcX
11/03/2022 10:18:20 59 1,980.50 XLON xsqArH2JBtm
11/03/2022 10:18:20 71 1,980.50 BATE xsqArH2JBto
11/03/2022 10:18:18 2 1,981.00 XLON xsqArH2JBtR
11/03/2022 10:18:18 76 1,981.00 XLON xsqArH2JBtT
11/03/2022 10:18:18 78 1,981.00 BATE xsqArH2JBtV
11/03/2022 10:18:14 104 1,982.50 BATE xsqArH2JBme
11/03/2022 10:17:40 4 1,982.00 XLON xsqArH2JB7Q
11/03/2022 10:17:40 98 1,982.00 XLON xsqArH2JB7S
11/03/2022 10:17:40 167 1,982.50 XLON xsqArH2JB7U
11/03/2022 10:17:40 98 1,982.50 BATE xsqArH2JB6Y
11/03/2022 10:17:40 35 1,983.00 BATE xsqArH2JB6a
11/03/2022 10:17:40 20 1,983.00 BATE xsqArH2JB6c
11/03/2022 10:17:40 387 1,983.00 XLON xsqArH2JB6W
11/03/2022 10:17:40 88 1,983.00 BATE xsqArH2JB6e
-- ENDS --
Enquiries:
Hikma Pharmaceuticals PLC
Peter Speirs +44 (0)20 7399 2772
Company Secretary
Susan Ringdal +44 (0)20 7399 2760
EVP Strategy and Global Affairs
About Hikma
Hikma helps put better health within reach every day for millions of people
around the world. For more than 40 years, we've been creating high-quality
medicines and making them accessible to the people who need them.
Headquartered in the UK, we are a global company with a local presence across
the United States (US), the Middle East and North Africa (MENA) and Europe,
and we use our unique insight and expertise to transform cutting-edge science
into innovative solutions that transform people's lives. We're committed to
our customers, and the people they care for, and by thinking creatively and
acting practically, we provide them with a broad range of branded and
non-branded generic medicines. Together, our 8,700 colleagues are helping to
shape a healthier world that enriches all our communities. We are a leading
licensing partner, and through our venture capital arm, are helping bring
innovative health technologies to people around the world. For more
information, please visit: www.hikma.com (http://www.hikma.com) .
(LEI:549300BNS685UXH4JI75)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSVFLFFLXLBBBKRecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement